InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Zinda Michael, Directeur Scientifique. Officer active across 1 company, notably Repare Therapeutics Inc.. In total, 17 filings have been logged. Breakdown: 0 buy · 12 sells. Total volume traded: €1.7m. History available since 17 May 2021. The latest transaction was disclosed on 12 March 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations17 total
5,611 shares@ US$1.140.3% of flowCommon SharesSEC:0001415889-25-008107:0
14,000 shares0Common SharesSEC:0001415889-25-007238:0
450 shares@ US$4.640.1% of flowCommon SharesSEC:0001415889-24-009625:0
450 shares@ US$4.780.1% of flowCommon SharesSEC:0001415889-24-009253:0
14,000 shares0Common SharesSEC:0001415889-24-006466:0
6,404 shares@ US$12.034.1% of flowCommon SharesSEC:0001209191-23-035858:0
1,200 shares@ US$12.040.8% of flowCommon SharesSEC:0001209191-23-035135:0
24,550 shares0Common SharesSEC:0001209191-23-006064:0
533 shares@ US$11.300.3% of flowCommon SharesSEC:0001209191-22-019202:0
4,122 shares@ US$1.6370.3% of flowCommon SharesSEC:0001209191-21-068113
4,122 shares@ US$1.6370.4% of flowCommon SharesSEC:0001209191-21-068113:0
16,100 shares@ US$27.2023.3% of flowCommon SharesSEC:0001209191-21-065302:0
16,100 shares@ US$27.2022.0% of flowCommon SharesSEC:0001209191-21-065302
14,300 shares@ US$33.9725.1% of flowCommon StockSEC:0001209191-21-052772:0
14,300 shares@ US$33.9723.7% of flowCommon StockSEC:0001209191-21-052772
732 shares@ US$31.64551.2% of flowCommon StockSEC:0001209191-21-033670
732 shares@ US$31.64551.2% of flowCommon StockSEC:0001209191-21-033670:0
17 of 17 declarations
About Zinda Michael
Michael Zinda is Executive Vice President and Chief Science Officer at Repare Therapeutics Inc. He is responsible for leading the company's research and development efforts, focusing on scientific innovation and the discovery of new treatments. Michael Zinda plays a crucial role in the strategic direction of research projects and in establishing scientific partnerships.
